The inhibition of the corrosion of metal implants is still a challenge. This study aimed to increase the corrosion resistance of Ti6Al7Nb alloy implants through surface modification, including grinding, sandblasting, and anodic oxidation followed by the deposition of a polymer coating. The aim of the work was to determine the influence of biodegradable polymer coatings on the physico-chemical properties of a Ti6Al7Nb alloy used for short-term implants. Biodegradable coatings prepared from poly(glycolide-caprolactone) (P(GCap)), poly(glycolide ε-caprolactone-lactide) (P(GCapL)), and poly(lactide-glycolide) (PLGA) were applied in the studies. The dip-coating method with three cycles of dipping was applied. Corrosion resistance was assessed on the basis of potentiodynamic studies. The studies were carried out on samples after 30, 60, and 90 days of exposure to Ringer's solution. Surface topography, wettability, and cytotoxicity studies were also carried out. The degradation process of the base material was evaluated on the basis of the mass density of the metal ions released to the solution. The results indicated the influence of the coating type on corrosion resistance. In addition, a beneficial effect of the polymer coating on the reduction of the density of the released metal ions was found, as compared to the samples without polymer coatings. The obtained results provide basic knowledge for the development of polymer coatings enriched with an active substance. The presence of ciprofloxacin in the coating did not reduce the corrosion resistance of the metal substrate. Moreover, the cytotoxicity test using the extract dilution method demonstrated that the implants' coatings are promising for further in vitro and in vivo studies.The extensive use of biodegradable polymers in medical applications is mainly associated with the possibility of tailoring their physicochemical and mechanical properties. Controlled polymer degradation allows for their use as carriers of medicinal substances, ensuring drug release with regulated dynamics to obtain the expected therapeutic effects [5]. The mentioned group of biopolymers is characterized by an appropriate biocompatibility [4], and the achieved degradation products-mainly lactic, glycolic, and hydroxyhexanoic acids-are found to be neutral to the human organism and are metabolized in accordance the Krebs cycle [6]. The basic limitation of the use of biodegradable polymers relates to the mechanical properties that change over time. This feature may be disadvantageous in some applications, e.g., orthopedic implants. Treatment disorders can be observed as the implant weakens due to degradation processes. This can lead to repeated injuries. The consequence of this is the need to perform a revision surgery combined with the removal of an incompletely degraded and mechanically weakened implant and followed by its replacement with a new one. The revision surgery due to the progressive degradation of the polymer material may be associated with serious difficulties that lead to a much ...